Key Takeaways from Dr. Brandon Ayres’s Presentation on Corneal Crosslinking
1. Understanding Progressive Keratoconus: Highlighting the importance of timely intervention, Dr. Ayres discussed distinguishing progressive keratoconus from its stable forms, emphasizing the urgency in treating the progressive condition.
2. The Science of CXL: Exploring the mechanics behind crosslinking, Dr. Ayres explained how UV-activated riboflavin is pivotal in strengthening corneal fibers to halt keratoconus progression.
3. Optimizing Post-Op Care: Insights on post-operative strategies were shared, focusing on managing recovery, optimal timing for refitting contact lenses, and monitoring potential complications such as delayed epithelial healing.
4. Navigating Insurance and Documentation Challenges: Dr. Ayres covered the critical aspects of documentation for insurance approvals for CXL, emphasizing the need for detailed evidence of disease progression.
5. Future Directions and Technological Advances: Discussing upcoming advancements, Dr. Ayres introduced 'epithelium-on' CXL techniques and additional treatments that could improve patient outcomes post-CXL.
Don’t miss the complete insights from Dr. Ayres’s talk. Be sure to go to WooU.org and check out the recording and handouts